Related Experiment Video

Updated: Aug 6, 2026

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
06:06

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

Breast cancer VPAC1 receptors

Terry W Moody1, Robert T Jensen

  • 1Department of Health and Human Services, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA. moodyt@mail.nih.gov

Annals of the New York Academy of Sciences
|August 5, 2006
PubMed

Insights

Vasoactive intestinal peptide (VIP) receptors were found in breast cancer tissues. VIP-targeted chemotherapy conjugates show potential for inhibiting breast cancer growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Vasoactive intestinal peptide (VIP) receptors are implicated in various cancers.
  • Understanding VIP receptor expression in breast cancer is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the presence and affinity of VIP receptors in breast cancer biopsy specimens.
  • To evaluate the potential of VIP-chemotherapeutic conjugates as a breast cancer treatment.

Main Methods:

  • Analysis of 125I-VIP binding in 20 breast cancer biopsy specimens.
  • Quantification of VPAC1 receptor mRNA in biopsy specimens.
  • Assessment of VIP chemotherapeutic conjugate binding to VPAC1 receptors in MCF-7 cells.

Main Results:

  • High-affinity binding of 125I-VIP was observed in all 20 biopsy specimens.
  • Elevated VPAC1 receptor mRNA levels were detected in all specimens.
  • The VIP chemotherapeutic conjugate demonstrated high-affinity binding to VPAC1 receptors on MCF-7 cells.

Conclusions:

  • Breast cancer tissues express functional VIP receptors, specifically VPAC1.
  • VIP-targeted chemotherapeutic conjugates represent a promising strategy for breast cancer therapy.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...